Vanderbilt-Led Study Into Promising COVID-19 Treatment Closes, Showing No Benefit Blake FarmerJune 21, 2020 A fast-tracked clinical trial exploring the potential benefits of hydroxychloroquine in treating COVID-19 has concluded as abruptly as it began.
Vanderbilt Doctor Leads Clinical Trial Of Drug That Could Treat COVID-19 Sergio Martínez-BeltránApril 9, 2020 There’s been a lot of talk lately about whether a drug that treats malaria could also be used to treat patients with COVID-19. So, a Vanderbilt doctor is leading the trial to understand if the drug — hydroxychloroquine — has any potential.